A Case Report of Hepatocellular Carcinoma 5 Years After HBsAg Loss in Chronic Hepatitis Delta: How Long Surveillance is Required?
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 4
Abstract
Background. Hepatitis delta virus infection occurs as acute co-infection or as superinfection in patients with preexisting chronic hepatitis B. Chronic hepatitis delta leads to more severe disease than chronic hepatitis B, with more rapid progression of fibrosis and increased risk of hepatocelullar carcinoma. Case report. We report a case of hepatocelullar carcinoma 5 years after spontaneous clearance of Hepatitis B surface antigen in a patient with previous chronic hepatitis delta. He had been diagnosed with acute hepatitis delta superinfection 30 years ago which evolved to chronic delta infection and subsequently development of liver cirrhosis. Despite no specific antiviral treatment, he lost HBsAg persistently with later regression of cirrhosis. Conclusions. In patients with cirrhosis due to chronic hepatitis delta who cleared HBsAg with improvement of liver fibrosis by non invasive techniques, it remains unknown how long hepatocelullar carcinoma surveillance has to be maintained.
Authors and Affiliations
Laura Escolà-Vergé, Mar Riveiro-Barciela, Maria Buti
Keywords
Related Articles
- EP ID EP189450
- DOI 10.5604/01.3001.0010.0314
- Views 79
- Downloads 0
The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico
The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report
Chronic hepatitis C virus (HCV) infection can be cured with treatment using direct-acting antivirals (DAAs). Although these drugs have been widely studied, information about certain special populations is missing. In thi...
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C
Introduction. In patients with chronic hepatitis C it is still debated whether previous exposure to the hepatitis B virus, diagnosed from the presence of the anti-HBc antibody, is linked to a greater risk of severe hepat...
Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice
Noninvasive markers of fibrosis have emerged as an alternative to the staging of fibrosis by means of liver biopsy. Apart from being noninvasive and thus lacking the adverse effects of liver biopsy, they offer some adva...
Platelet count/spleen diameter ratio as a predictor of esophageal varices in cirrhotic patients